2014

Reveal Insider Trading for Bank of America, Rite Aid, NetApp, Pfizer, Cisco, and EMC

HONG KONG, July 16, 2013 /PRNewswire/ -- Insiderslab.com has released insider trading report for the following stocks: Bank of America (NYSE: BAC), Rite Aid (NYSE: RAD), NetApp (NASDAQ: NTAP), Pfizer (NYSE: PFE), Cisco (NASDAQ: CSCO), and EMC (NYSE: EMC).

(Logo: http://photos.prnewswire.com/prnh/20100419/HKM001LOGO)

(Read full report by clicking the link below, you may need to copy and paste the full link to your browser.)

Report Highlights:

Bank of America Corp. (NYSE: BAC): By the end of last trading session, the shares of Bank of America (NYSE: BAC) earned US$0.10 (or 0.73%) to US$13.88 with 90.77 million shares exchanged hands, compared to daily average volume of 119.08 million. Insiderslab.com found company insiders sold his/her shares for about US$7.59 million in last month. Investors may want to find out how Bank of America insiders like CEOs, CFOs and Directors are thinking about the future of the company. Check this insider trade report for BAC here.

Read Full Report: http://www.insiderslab.com/PR3/071613A/BAC/BankofAmerica.pdf

Rite Aid Corporation (NYSE: RAD): By the end of last trading session, Rite Aid (NYSE: RAD) shares rose 1.07% to US$2.83 with about 13.26 million shares exchanged hands for the session, compared to its average volume of 24.09 million shares. Insiderslab.com found company SVP, Douglas E. Donley, sold his shares at price of US$2.80 on July 12. Investors may want to find out how Rite Aid insiders like CEOs, CFOs and Directors are thinking about the future of the company.

Read Full Report: http://www.insiderslab.com/PR3/071613A/RAD/RiteAid.pdf

NetApp Inc. (NASDAQ: NTAP): By the end of last trading session, NetApp (NASDAQ: NTAP) jumped 2.04% to US$40.10 with about 9.42 million shares exchanged hands for the session, compared to its average volume of 5.21 million shares. During last trading session, the share hit the 52-week high of US$40.48. Insiderslab.com found company Director, Daniel J. Warmenhoven, sold his shares at price of US$39.25 on July 11. Insiderslab.com believes that it is a clever way to check if insiders like CEOs, CFOs, and Directors in NetApp are starting to sell more company shares. See insider trade report for NTAP here.

Read Full Report: http://www.insiderslab.com/PR3/071613A/NTAP/NetApp.pdf

Today Insiderslab.com also observed abnormal trade volume for the following companies; insiders may involve trading in these companies. It will take some time for insiders to report their trades. Read these reports and add these companies into your Insider Trade Radar.

Pfizer Inc. (NYSE: PFE):

Read Full Report: http://www.insiderslab.com/PR3/071613A/PFE/Pfizer.pdf

Cisco (NASDAQ: CSCO):

Read Full Report: http://www.insiderslab.com/PR3/071613A/CSCO/Cisco.pdf

EMC (NYSE: EMC):

Read Full Report: http://www.insiderslab.com/PR3/071613A/EMC/EMC.pdf

Insider Filing Source Reference: All observations, analyses and reports are based on public information released by the U.S. Securities and Exchange Commission.

About Insiderslab.com:

Insiderslab.com covers insider trade data in major stock markets in the U.S., Hong Kong, Mainland China, and Singapore.  Insiderslab.com features a team of experienced data analysts striving to provide the investment community with the tools, software, and data necessary to carry out more effective investment research.

Important Disclaimer:

Please visit insiderslab.com/disclaimers/disclaimers.php for details.

SOURCE Insiderslab.com; Insiders.hk



RELATED LINKS
http://www.insiderslab.com/indexPR.php
http://www.insiderslab.com
http://insiderslab.com/disclaimers/disclaimers.php
http://www.insiderslab.com/media/news/1432/

More by this Source


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.